Global Vaccines Market Growth 2022-2028
As the global economy mends, the 2021 growth of Vaccines will have significant change from previous year. According to our latest study, the global Vaccines market size is USD million in 2022 from USD 44300 million in 2021, with a change of % between 2021 and 2022. The global Vaccines market size will reach USD 65770 million in 2028, growing at a CAGR of 5.8% over the analysis period.
The United States Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vaccines market, reaching US$ million by the year 2028. As for the Europe Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Vaccines players cover GSK, Sanofi, Merck, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccines Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vaccines by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vaccines by Country/Region, 2017, 2022 & 2028
2.2 Vaccines Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Vaccines Sales by Type
2.3.1 Global Vaccines Sales Market Share by Type (2017-2022)
2.3.2 Global Vaccines Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vaccines Sale Price by Type (2017-2022)
2.4 Vaccines Segment by Application
2.4.1 Rabies vaccine
2.4.2 Influenza vaccine
2.4.3 HPV vaccine
2.4.4 Hepatitis B
2.4.5 Hepatitis A
2.4.6 Leprosy vaccine
2.4.7 Polio vaccine
2.4.8 JE vaccine
2.4.9 Others
2.5 Vaccines Sales by Application
2.5.1 Global Vaccines Sale Market Share by Application (2017-2022)
2.5.2 Global Vaccines Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vaccines Sale Price by Application (2017-2022)
3 Global Vaccines by Company
3.1 Global Vaccines Breakdown Data by Company
3.1.1 Global Vaccines Annual Sales by Company (2020-2022)
3.1.2 Global Vaccines Sales Market Share by Company (2020-2022)
3.2 Global Vaccines Annual Revenue by Company (2020-2022)
3.2.1 Global Vaccines Revenue by Company (2020-2022)
3.2.2 Global Vaccines Revenue Market Share by Company (2020-2022)
3.3 Global Vaccines Sale Price by Company
3.4 Key Manufacturers Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccines Product Location Distribution
3.4.2 Players Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vaccines by Geographic Region
4.1 World Historic Vaccines Market Size by Geographic Region (2017-2022)
4.1.1 Global Vaccines Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vaccines Annual Revenue by Geographic Region
4.2 World Historic Vaccines Market Size by Country/Region (2017-2022)
4.2.1 Global Vaccines Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vaccines Annual Revenue by Country/Region
4.3 Americas Vaccines Sales Growth
4.4 APAC Vaccines Sales Growth
4.5 Europe Vaccines Sales Growth
4.6 Middle East & Africa Vaccines Sales Growth
5 Americas
5.1 Americas Vaccines Sales by Country
5.1.1 Americas Vaccines Sales by Country (2017-2022)
5.1.2 Americas Vaccines Revenue by Country (2017-2022)
5.2 Americas Vaccines Sales by Type
5.3 Americas Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines Sales by Region
6.1.1 APAC Vaccines Sales by Region (2017-2022)
6.1.2 APAC Vaccines Revenue by Region (2017-2022)
6.2 APAC Vaccines Sales by Type
6.3 APAC Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vaccines by Country
7.1.1 Europe Vaccines Sales by Country (2017-2022)
7.1.2 Europe Vaccines Revenue by Country (2017-2022)
7.2 Europe Vaccines Sales by Type
7.3 Europe Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccines by Country
8.1.1 Middle East & Africa Vaccines Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vaccines Revenue by Country (2017-2022)
8.2 Middle East & Africa Vaccines Sales by Type
8.3 Middle East & Africa Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccines
10.3 Manufacturing Process Analysis of Vaccines
10.4 Industry Chain Structure of Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccines Distributors
11.3 Vaccines Customer
12 World Forecast Review for Vaccines by Geographic Region
12.1 Global Vaccines Market Size Forecast by Region
12.1.1 Global Vaccines Forecast by Region (2023-2028)
12.1.2 Global Vaccines Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccines Forecast by Type
12.7 Global Vaccines Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Vaccines Product Offered
13.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Vaccines Product Offered
13.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Vaccines Product Offered
13.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Vaccines Product Offered
13.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Novartis(GSK)
13.5.1 Novartis(GSK) Company Information
13.5.2 Novartis(GSK) Vaccines Product Offered
13.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis(GSK) Main Business Overview
13.5.5 Novartis(GSK) Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Vaccines Product Offered
13.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 MedImmune LLC
13.7.1 MedImmune LLC Company Information
13.7.2 MedImmune LLC Vaccines Product Offered
13.7.3 MedImmune LLC Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 MedImmune LLC Main Business Overview
13.7.5 MedImmune LLC Latest Developments
13.8 J&J(Crucell)
13.8.1 J&J(Crucell) Company Information
13.8.2 J&J(Crucell) Vaccines Product Offered
13.8.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 J&J(Crucell) Main Business Overview
13.8.5 J&J(Crucell) Latest Developments
13.9 China National Biotec
13.9.1 China National Biotec Company Information
13.9.2 China National Biotec Vaccines Product Offered
13.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 China National Biotec Main Business Overview
13.9.5 China National Biotec Latest Developments
13.10 Tiantan
13.10.1 Tiantan Company Information
13.10.2 Tiantan Vaccines Product Offered
13.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Tiantan Main Business Overview
13.10.5 Tiantan Latest Developments
13.11 Hualan
13.11.1 Hualan Company Information
13.11.2 Hualan Vaccines Product Offered
13.11.3 Hualan Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hualan Main Business Overview
13.11.5 Hualan Latest Developments
13.12 Kangtai
13.12.1 Kangtai Company Information
13.12.2 Kangtai Vaccines Product Offered
13.12.3 Kangtai Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Kangtai Main Business Overview
13.12.5 Kangtai Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Vaccines Product Offered
13.13.3 Hissen Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
13.14 Jintan
13.14.1 Jintan Company Information
13.14.2 Jintan Vaccines Product Offered
13.14.3 Jintan Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Jintan Main Business Overview
13.14.5 Jintan Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Vaccines Sales by Type (2017-2022) & (K Pcs)
Table 8. Global Vaccines Sales Market Share by Type (2017-2022)
Table 9. Global Vaccines Revenue by Type (2017-2022) & ($ million)
Table 10. Global Vaccines Revenue Market Share by Type (2017-2022)
Table 11. Global Vaccines Sale Price by Type (2017-2022) & (US$/Pcs)
Table 12. Global Vaccines Sales by Application (2017-2022) & (K Pcs)
Table 13. Global Vaccines Sales Market Share by Application (2017-2022)
Table 14. Global Vaccines Revenue by Application (2017-2022)
Table 15. Global Vaccines Revenue Market Share by Application (2017-2022)
Table 16. Global Vaccines Sale Price by Application (2017-2022) & (US$/Pcs)
Table 17. Global Vaccines Sales by Company (2020-2022) & (K Pcs)
Table 18. Global Vaccines Sales Market Share by Company (2020-2022)
Table 19. Global Vaccines Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Vaccines Revenue Market Share by Company (2020-2022)
Table 21. Global Vaccines Sale Price by Company (2020-2022) & (US$/Pcs)
Table 22. Key Manufacturers Vaccines Producing Area Distribution and Sales Area
Table 23. Players Vaccines Products Offered
Table 24. Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vaccines Sales by Geographic Region (2017-2022) & (K Pcs)
Table 28. Global Vaccines Sales Market Share Geographic Region (2017-2022)
Table 29. Global Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Vaccines Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Vaccines Sales by Country/Region (2017-2022) & (K Pcs)
Table 32. Global Vaccines Sales Market Share by Country/Region (2017-2022)
Table 33. Global Vaccines Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Vaccines Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Vaccines Sales by Country (2017-2022) & (K Pcs)
Table 36. Americas Vaccines Sales Market Share by Country (2017-2022)
Table 37. Americas Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Vaccines Revenue Market Share by Country (2017-2022)
Table 39. Americas Vaccines Sales by Type (2017-2022) & (K Pcs)
Table 40. Americas Vaccines Sales Market Share by Type (2017-2022)
Table 41. Americas Vaccines Sales by Application (2017-2022) & (K Pcs)
Table 42. Americas Vaccines Sales Market Share by Application (2017-2022)
Table 43. APAC Vaccines Sales by Region (2017-2022) & (K Pcs)
Table 44. APAC Vaccines Sales Market Share by Region (2017-2022)
Table 45. APAC Vaccines Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Vaccines Revenue Market Share by Region (2017-2022)
Table 47. APAC Vaccines Sales by Type (2017-2022) & (K Pcs)
Table 48. APAC Vaccines Sales Market Share by Type (2017-2022)
Table 49. APAC Vaccines Sales by Application (2017-2022) & (K Pcs)
Table 50. APAC Vaccines Sales Market Share by Application (2017-2022)
Table 51. Europe Vaccines Sales by Country (2017-2022) & (K Pcs)
Table 52. Europe Vaccines Sales Market Share by Country (2017-2022)
Table 53. Europe Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Vaccines Revenue Market Share by Country (2017-2022)
Table 55. Europe Vaccines Sales by Type (2017-2022) & (K Pcs)
Table 56. Europe Vaccines Sales Market Share by Type (2017-2022)
Table 57. Europe Vaccines Sales by Application (2017-2022) & (K Pcs)
Table 58. Europe Vaccines Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Vaccines Sales by Country (2017-2022) & (K Pcs)
Table 60. Middle East & Africa Vaccines Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vaccines Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Vaccines Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Vaccines Sales by Type (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Vaccines Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Vaccines Sales by Application (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Vaccines Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Vaccines
Table 68. Key Market Challenges & Risks of Vaccines
Table 69. Key Industry Trends of Vaccines
Table 70. Vaccines Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Vaccines Distributors List
Table 73. Vaccines Customer List
Table 74. Global Vaccines Sales Forecast by Region (2023-2028) & (K Pcs)
Table 75. Global Vaccines Sales Market Forecast by Region
Table 76. Global Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Vaccines Sales Forecast by Country (2023-2028) & (K Pcs)
Table 79. Americas Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Vaccines Sales Forecast by Region (2023-2028) & (K Pcs)
Table 81. APAC Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Vaccines Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Europe Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Vaccines Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Middle East & Africa Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Vaccines Sales Forecast by Type (2023-2028) & (K Pcs)
Table 87. Global Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Vaccines Sales Forecast by Application (2023-2028) & (K Pcs)
Table 91. Global Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 94. GSK Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. GSK Vaccines Product Offered
Table 96. GSK Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 97. GSK Main Business
Table 98. GSK Latest Developments
Table 99. Sanofi Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Vaccines Product Offered
Table 101. Sanofi Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. Merck Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Vaccines Product Offered
Table 106. Merck Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Pfizer Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. Pfizer Vaccines Product Offered
Table 111. Pfizer Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 112. Pfizer Main Business
Table 113. Pfizer Latest Developments
Table 114. Novartis(GSK) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. Novartis(GSK) Vaccines Product Offered
Table 116. Novartis(GSK) Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 117. Novartis(GSK) Main Business
Table 118. Novartis(GSK) Latest Developments
Table 119. CSL Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120. CSL Vaccines Product Offered
Table 121. CSL Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 122. CSL Main Business
Table 123. CSL Latest Developments
Table 124. MedImmune LLC Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. MedImmune LLC Vaccines Product Offered
Table 126. MedImmune LLC Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 127. MedImmune LLC Main Business
Table 128. MedImmune LLC Latest Developments
Table 129. J&J(Crucell) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. J&J(Crucell) Vaccines Product Offered
Table 131. J&J(Crucell) Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 132. J&J(Crucell) Main Business
Table 133. J&J(Crucell) Latest Developments
Table 134. China National Biotec Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 135. China National Biotec Vaccines Product Offered
Table 136. China National Biotec Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 137. China National Biotec Main Business
Table 138. China National Biotec Latest Developments
Table 139. Tiantan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 140. Tiantan Vaccines Product Offered
Table 141. Tiantan Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 142. Tiantan Main Business
Table 143. Tiantan Latest Developments
Table 144. Hualan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 145. Hualan Vaccines Product Offered
Table 146. Hualan Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 147. Hualan Main Business
Table 148. Hualan Latest Developments
Table 149. Kangtai Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 150. Kangtai Vaccines Product Offered
Table 151. Kangtai Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 152. Kangtai Main Business
Table 153. Kangtai Latest Developments
Table 154. Hissen Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 155. Hissen Vaccines Product Offered
Table 156. Hissen Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 157. Hissen Main Business
Table 158. Hissen Latest Developments
Table 159. Jintan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 160. Jintan Vaccines Product Offered
Table 161. Jintan Vaccines Sales (K Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)
Table 162. Jintan Main Business
Table 163. Jintan Latest Developments
List of Figures
Figure 1. Picture of Vaccines
Figure 2. Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccines Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Vaccines Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vaccines Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Recombinant Vaccines
Figure 10. Product Picture of Viral Vaccines
Figure 11. Product Picture of Polysaccharide Vaccines
Figure 12. Product Picture of Others
Figure 13. Global Vaccines Sales Market Share by Type in 2021
Figure 14. Global Vaccines Revenue Market Share by Type (2017-2022)
Figure 15. Vaccines Consumed in Rabies vaccine
Figure 16. Global Vaccines Market: Rabies vaccine (2017-2022) & (K Pcs)
Figure 17. Vaccines Consumed in Influenza vaccine
Figure 18. Global Vaccines Market: Influenza vaccine (2017-2022) & (K Pcs)
Figure 19. Vaccines Consumed in HPV vaccine
Figure 20. Global Vaccines Market: HPV vaccine (2017-2022) & (K Pcs)
Figure 21. Vaccines Consumed in Hepatitis B
Figure 22. Global Vaccines Market: Hepatitis B (2017-2022) & (K Pcs)
Figure 23. Vaccines Consumed in Hepatitis A
Figure 24. Global Vaccines Market: Hepatitis A (2017-2022) & (K Pcs)
Figure 25. Vaccines Consumed in Leprosy vaccine
Figure 26. Global Vaccines Market: Leprosy vaccine (2017-2022) & (K Pcs)
Figure 27. Vaccines Consumed in Polio vaccine
Figure 28. Global Vaccines Market: Polio vaccine (2017-2022) & (K Pcs)
Figure 29. Vaccines Consumed in JE vaccine
Figure 30. Global Vaccines Market: JE vaccine (2017-2022) & (K Pcs)
Figure 31. Vaccines Consumed in Others
Figure 32. Global Vaccines Market: Others (2017-2022) & (K Pcs)
Figure 33. Global Vaccines Sales Market Share by Application (2017-2022)
Figure 34. Global Vaccines Revenue Market Share by Application in 2021
Figure 35. Vaccines Revenue Market by Company in 2021 ($ Million)
Figure 36. Global Vaccines Revenue Market Share by Company in 2021
Figure 37. Global Vaccines Sales Market Share by Geographic Region (2017-2022)
Figure 38. Global Vaccines Revenue Market Share by Geographic Region in 2021
Figure 39. Global Vaccines Sales Market Share by Region (2017-2022)
Figure 40. Global Vaccines Revenue Market Share by Country/Region in 2021
Figure 41. Americas Vaccines Sales 2017-2022 (K Pcs)
Figure 42. Americas Vaccines Revenue 2017-2022 ($ Millions)
Figure 43. APAC Vaccines Sales 2017-2022 (K Pcs)
Figure 44. APAC Vaccines Revenue 2017-2022 ($ Millions)
Figure 45. Europe Vaccines Sales 2017-2022 (K Pcs)
Figure 46. Europe Vaccines Revenue 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Vaccines Sales 2017-2022 (K Pcs)
Figure 48. Middle East & Africa Vaccines Revenue 2017-2022 ($ Millions)
Figure 49. Americas Vaccines Sales Market Share by Country in 2021
Figure 50. Americas Vaccines Revenue Market Share by Country in 2021
Figure 51. United States Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 52. Canada Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 53. Mexico Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 54. Brazil Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 55. APAC Vaccines Sales Market Share by Region in 2021
Figure 56. APAC Vaccines Revenue Market Share by Regions in 2021
Figure 57. China Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 58. Japan Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Korea Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 60. Southeast Asia Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 61. India Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 62. Australia Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 63. Europe Vaccines Sales Market Share by Country in 2021
Figure 64. Europe Vaccines Revenue Market Share by Country in 2021
Figure 65. Germany Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 66. France Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 67. UK Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 68. Italy Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 69. Russia Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 70. Middle East & Africa Vaccines Sales Market Share by Country in 2021
Figure 71. Middle East & Africa Vaccines Revenue Market Share by Country in 2021
Figure 72. Egypt Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 73. South Africa Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 74. Israel Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 75. Turkey Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 76. GCC Country Vaccines Revenue Growth 2017-2022 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Vaccines in 2021
Figure 78. Manufacturing Process Analysis of Vaccines
Figure 79. Industry Chain Structure of Vaccines
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
